Md. Ershadul Karim, LL.B. (Hons.), LL.M. (University of Dhaka, Bangladesh), PhD in Nanotechnology Law and Policy (University of Malaya, Malaysia) is an Associate Professor of Law at the Faculty of Law of Universiti Malaya (UM). He joined UM as Senior Lecturer after completion of his PhD with the very prestigious Bright Spark Scholarship.    Being a passionate researcher and academic, Dr. Karim has widely published in peer-reviewed Journals and presented papers at many national and international Conferences in his areas of interest i.e. ‘information and communication technology’, ‘artificial intelligence’, ‘legal and regulatory aspects of nanotechnology’, ‘emerging technologies and law’, ‘privacy and data protection law’, ‘health and medical law’, ‘legal research’, and ‘Asian and comparative law’, etc. Ershadul authored six books and is the author of Cyber Law in Bangladesh, Kluwer Law International, 2022 (2nd Edition), Environmental Law in Bangladesh, Kluwer Law International, 2024 (2nd Edition), Privacy and Personal Data Protection Law in Bangladesh, Kluwer Law International, 2024, and co-author of Personal Data Protection Law in Asia (second edition), Thomson and Reuters, 2018. Dr. Karim has been managing the National Chapter on Bangladesh for the Yearbook of International Environmental Law published by Oxford University, the United Kingdom since 2013. Dr. Ershadul has written Chapters on the Legal System of Afghanistan, Bangladesh, Bhutan, Iran, Nepal, Maldives, and Myanmar in GlobaLex, New York University, USA. He has also developed the Research Guide on Nanotechnology Law and Policy, and SAARC for the same database. Ershadul has published more than fifty peer-reviewed academic papers and contributed chapters in books published by the United Kingdom’s Royal Society of Chemistry, Elsevier Inc., SpringerNature and BRILL analysing, inter alia, the relationship between nanomaterials and international environmental law, various legal and regulatory issues in polymer nanocomposite, functionalised nanomaterials, biosensors, consumer nanoproducts, international renewable energy law, and nuclear energy law. Dr. Ershadul is the Managing Editor of one of the oldest law journals in Malaysia and the flagship journal of the Faculty of Law, UM — the Journal of Malaysian and Comparative Law. He has reviewed more than a hundred articles and book proposals for all major and renowned academic publishers worldwide. As an enlisted lawyer with the Bangladesh Bar Council and Bangladesh Supreme Court, Dr. Karim was instrumental in developing the Bangladesh Code, a collection of 38 volumes containing all existing Acts of Parliament, Ordinances and President’s Orders in force in Bangladesh between 1836-2006. He was also the Web Administrator and Editor of the first ever online case law database of Bangladesh, Chancery Law Chronicles [www.clcbd.org] for six years.   Dr. Karim served as Senior Research Officer at the Technical Support Secretariat of the United Nations Special Rapporteur on Trafficking in Women and Children for three years. So far Dr. Karim and his team have received grants of more than USD 2,00,000 to research different legal and policy issues. He was a member of the research team in the “INDUSTRY-ACADEMIA COLLABORATIVE BLOCKCHAIN-BASED REGULATORY FRAMEWORK RESEARCH PROJECT”. Dr. Karim has been consulted by different national and international organisations including Japan Government's Patent Office through Kyoto Comparative Law Center, United Nations Development Program (UNDP), UN Women, World Intellectual Property Organisation (WIPO), World Bank Group, European Union, Canadian International Development Agency (CIDA), Japan International Cooperative Agency (JICA), Consumer International, Prime Minister’s Office of the Government of Malaysia and Ministry of Justice, United Arab Emirates, Transparency International, Bangladesh, ARTICLE 19, and Qatar Foundation. Ershadul has been interviewed by Prothom Alo, the largest circulated newspaper in Bangladesh several times, the Daily Star (Bangladesh) [largest circulating English-language newspaper in Bangladesh], the Star (Malaysia) [largest paid English newspaper in terms of circulation in Malaysia], and has also been quoted in the several news media including the Prothom Alo and BBC Bangla. Ershadul is a member of the International Network Initiative on Safe and Sustainable Nanotechnology, and covers the Asian legal systems. He is also a member of the Global AI Ethics Consortium (Technical University of Munich, Germany). Ershadul is a supervisor and examiner of PhD theses and Master's dissertations in his areas of interest and expertise. Ershadul has recently developed interests in exploring the history and philosophy of technologies, technology regulation theories, sociology of technologies, science and technology studies, and is available to supervise research students willing to explore the legal aspects in these areas.

A Senior Lecturer at the Department of Drama, Faculty of Creative Arts. An alumnus of the Cultural Centre, University of Malaya with a background in dance and drama. Specialize in Drama/Theatre (in) education, Arts-Management and Cross/inter-Disciplinary Exchange. My research at the postgraduate level concentrated on the use of drama and performance for the second (English) language classroom which identified its related set of challenges and possibilities. I further obtained a PhD in Theatre Studies from the University of Warwick in which my thesis examined the nature of MAKUM Theatre Festival as a form of university theatre modelled by the Creative Campus. One of the aims of this endeavor was to document theatre as conceptualized and fashioned by the general division of arts and non-arts students. I thus engage in arts (theatre) management and drama for education at both the undergraduate and postgraduate levels, and currently serves as Postgraduate Program Coordinator. My research interest lies in the application of drama and theatre as creative, innovative and alternative method to teaching and learning, as well as further developments in drama with technology for advancement. Central to my studies is the role of drama/theatre for human development, focusing on issues that relate to dramatic and theatrical application within and outside the field. Along this line is the significant impact of the performing arts on doers (performers) as well as observers (audience). Experienced in mixed-method research, instrumentation design, and continuously seeks opportunities for collaborative and cooperative efforts for the further expansion of drama/theatre application, both formal and informal, in and outside academia.

Professor Dr. See Mee-Hoong Professor Dr. See Mee-Hoong is an esteemed senior lecturer at the University of Malaya and a dedicated Consultant Oncoplastic Breast Surgeon at the University Malaya Medical Center (UMMC). Graduating with her undergraduate medical degree from UPM in 2003, she continued her academic excellence by earning her Master's Degree in Surgery (General Surgery) from the University of Malaya in May 2011 and obtained her fellowship in Breast Oncoplastic training from 2012 to 2015 in Universiti Malaya and Mahidol University, Thailand. Currently, she is nationally registered as a Breast Oncoplastic Surgeon. Her commitment to medical education and clinical practice led her to join the University Malaya Medical Faculty in 2012, where she specialized as a clinical lecturer focusing on Breast Oncoplastic Surgery. Dr. See further honed her skills as an honorary fellow at Siriraj Hospital, Mahidol University, Bangkok, Thailand in 2013, and later completed advanced training in minimally invasive techniques and Cryoablation at Kameda Medical Centre under Dr. Eisuke Fukuma in 2016. In 2022, Dr. See underwent robotic breast surgery training at Chang Hua Christian Medical Centre, Taichung, Taiwan. She has since pioneered minimally invasive breast surgeries at UMMC, offering patients the benefits of early recovery, smaller scars, better aesthetic outcomes, and comparable oncological results. A pioneer in Malaysia, she introduced 2D and 3D endoscopic nipple-sparing mastectomy (NSM) as early as 2019 and pioneer the FIRST MALAYSIA Robotic NSM with immediate implant reconstruction in 2025 . She has also been elected as a council member of Breast Surgical International in 2024, marking significant milestones in her leadership and expertise. Dr. See serves as the clinical head of the Breast Surgery Unit at UMMC (currently known as the Breast and Endocrine Unit), where she leads a team committed to providing high-quality care to patients. Her research interests span Clinical Breast Surgical Oncology, including Oncoplastic Surgery, Minimally Invasive and Robotic Breast Surgery, Enhanced Recovery After Surgery (ERAS), and Intraoperative Radiotherapy (IORT). She has published over 70 scientific papers, led the development of Decision Aids in Breast Reconstruction, and is actively involved in multiple clinical trials, including the TARGIT-B trial. Dr. See is also actively engaged in advancing artificial intelligence (AI) in breast cancer diagnosis. She is currently collaborating with Kyungpook National University, Daegu, South Korea, on a clinical trial exploring AI applications for breast cancer diagnostics and treatment planning. A driving force in Dr. See's work is her passion for uniting Southeast Asian and Asian breast surgeons through knowledge sharing and collaboration. She spearheads this effort through the Asian Breast Surgery Forum (ABSF – an ECHO Project), which she leads in collaboration with the University of New Mexico’s Project ECHO®. The forum connects 12 Asian countries, fostering the exchange of expertise and best practices in breast surgery. Dr. See is actively involved in various international surgical organizations, including the International Oncoplastic Breast Surgery (IOPBS) and the International Endoscopic and Robotic Breast Surgery (IERBS) societies, contributing to the global advancement of breast surgical practices. Currently, Dr. See serves as the Deputy Head of the Visibility Unit in the Faculty of Medicine at the University of Malaya. Her leadership and vision continue to impact the field of breast surgery, both regionally and globally, as she remains dedicated to enhancing surgical standards, research, and patient outcomes.